Amrize AG (AMRZ)
NYSE: AMRZ · Real-Time Price · USD
47.64
+0.99 (2.12%)
Aug 8, 2025, 10:58 AM - Market open
Revance Therapeutics Employees
Amrize AG had 19,000 employees as of December 31, 2024. The number of employees increased by 1,600 or 9.20% compared to the previous year.
Employees
19,000
Change (1Y)
1,600
Growth (1Y)
9.20%
Revenue / Employee
$611,526
Profits / Employee
$64,789
Market Cap
25.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19,000 | 1,600 | 9.20% |
| Dec 31, 2023 | 17,400 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CRH plc | 79,800 |
| Linde | 65,289 |
| The Sherwin-Williams Company | 63,890 |
| Rio Tinto Group | 55,561 |
| Ecolab | 48,000 |
| BHP Group | 40,094 |
| Freeport-McMoRan | 28,500 |
| Air Products and Chemicals | 23,000 |
AMRZ News
- 1 day ago - Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength - Business Wire
- 17 days ago - Amrize Announces Date for Second Quarter 2025 Financial Results - Business Wire
- 23 days ago - Amrize and Meta Partner on First-of-its-kind AI-Optimized Advanced Concrete Mix for Data Center in Minnesota - Business Wire
- 4 weeks ago - Holcim Completes Spin-Off Of Amrize On June 23 - Forbes
- 5 weeks ago - Amrize AG: Buy To 'Cement' Your Future - Seeking Alpha
- 6 weeks ago - Amrize Debuts as Independent, Publicly Traded Company - Business Wire